drugset / Trial / NCT00003238

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00003238 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different way to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic prostate cancer that has not responded to hormone therapy with androgens.

Timeline

Start
1998-02
Primary completion
2001-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject perillyl alcohol Small molecule — Oral

Indications